Design, synthesis and evaluation of novel 5, 6, 7-trimethoxyflavone–6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer's disease

2013 Alzheimer's disease facts and figures

Thies, W. H., & Bleiler, L. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,331 · see citing works

New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs

Salomone, S., Caraci, F., Leggio, G. M., Fedotova, J., & Drago, F. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04134.x · Cited by 322 · see citing works

Drug repositioning for Alzheimer's disease

Corbett, A., Pickett, J., Burns, A. S., Corcoran, J. P. T., Dunnett, S. B., Edison, P., Hagan, J. J., Holmes, C., Jones, E., Katona, C., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3869 · Cited by 302 · see citing works

New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties

Fernández‐Bachiller, M. I., Pérez, C., Monjas, L., Rademann, J., & Rodrı́guez-Franco, M. I. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201460y · Cited by 271 · see citing works

Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges

Morphy, R., & Ranković, Z. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315594 · Cited by 262 · see citing works

Pharmacological effects and pharmacokinetics properties ofRadix Scutellariaeand its bioactive flavones

Li, C., Lin, G., & Zuo, Z. (2011) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.771 · Cited by 243 · see citing works

Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer’s Disease

Lu, C., Guo, Y., Yan, J., Luo, Z., Luo, H., Yan, M., Huang, L., & Li, X. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400567s · Cited by 230 · see citing works

Rational Design of a Structural Framework with Potential Use to Develop Chemical Reagents That Target and Modulate Multiple Facets of Alzheimer’s Disease

Lee, S., Zheng, X., Krishnamoorthy, J., Savelieff, M. G., Park, H. M., Brender, J., Kim, J. H., Derrick, J. S., Kochi, A., Lee, H. J., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja409801p · Cited by 185 · see citing works

Pyrano[3,2-c]quinoline−6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds

Camps, P., Formosa, X., Galdeano, C., Muñoz‐Torrero, D., Ramírez, L., Gómez, E., Isambert, N., Lavilla, R., Badı́a, A., Clos, M. V., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900859q · Cited by 174 · see citing works

Alzheimer Disease and the Role of Free Radicals in the Pathogenesis of the Disease

Perry, G. L., Moreira, P. I., Santos, M. S., Oliveira, C. R., Shenk, J. C., Nunomura, A., Smith, M. A., & Zhu, X. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708783885156 · Cited by 155 · see citing works

Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer’s Disease

Huang, L., Lu, C., Sun, Y., Mao, F., Luo, Z., Su, T., Jiang, H., Shan, W., & Li, X. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300978h · Cited by 153 · see citing works

Design, synthesis and neuroprotective evaluation of novel tacrine–benzothiazole hybrids as multi-targeted compounds against Alzheimer’s disease

Keri, R. S., Quintanova, C., Marques, S. M., Esteves, A. R., Cardoso, S. M., & Santos, M. A. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.028 · Cited by 107 · see citing works

Design, synthesis and pharmacological evaluation of novel tacrine–caffeic acid hybrids as multi-targeted compounds against Alzheimer’s disease

Chao, X., He, X., Yang, Y., Zhou, X., Jin, M., Liu, S., Cheng, Z., Liu, P., Wang, Y., Yu, J., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.036 · Cited by 103 · see citing works

Multifunctional tacrine–flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease

Li, S., Wang, X., Xie, S., Jiang, N., Wang, K. D. G., Yao, H., Sun, H., & Kong, L. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.09.024 · Cited by 97 · see citing works

Design, synthesis and evaluation of novel tacrine–rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease

Li, S., Jiang, N., Xie, S., Wang, K. D. G., Wang, X., & Kong, L. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob42010h · Cited by 96 · see citing works

Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer’s disease

Li, R., Wang, X., Hu, X.-J., & Kong, L. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.095 · Cited by 94 · see citing works

Potential Therapeutic Effects of Baicalein, Baicalin, and Wogonin in Ocular Disorders

Xiao, J.-R., Wai, C., & To, C. H. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2014.0074 · Cited by 84 · see citing works

Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation

Luo, W., Li, Y., He, Y., Huang, S., Tan, J., Ou, T., Li, D., Gu, L., & Huang, Z. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.022 · Cited by 80 · see citing works

Carbamate Derivatives of Indolines as Cholinesterase Inhibitors and Antioxidants for the Treatment of Alzheimer’s Disease

Yanovsky, I., Finkin-Groner, E., Zaikin, A., Lerman, L., Shalom, H., Zeeli, S., Weill, T., Ginsburg, I., Nudelman, A., & Weinstock, M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301411g · Cited by 77 · see citing works

Design, Synthesis, and Biological Evaluation of ( E )-3,4-Dihydroxystyryl Aralkyl Sulfones and Sulfoxides as Novel Multifunctional Neuroprotective Agents

Ning, X., Guo, Y. Q., Wang, X., Ma, X., Tian, C., Shi, X., Zhu, R., Cheng, C., Du, Y., Ma, Z., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500258v · Cited by 69 · see citing works

Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies

Pietro, O. D., Pérez-Areales, F. J., Juárez‐Jiménez, J., Espargaró, A., Clos, M. V., Pérez, B., Lavilla, R., Sabaté, R., Luque, F. J., & Muñoz‐Torrero, D. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.021 · Cited by 67 · see citing works

Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies

Nakajima, A., Ohizumi, Y., & Yamada, K. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.2.75 · Cited by 64 · see citing works

Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity

Mao, F., Chen, J., Zhou, Q., Luo, Z., Huang, L., & Li, X. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.034 · Cited by 62 · see citing works

Antiviral activity of 5,6,7-trimethoxyflavone and its potentiation of the antiherpes activity of acyclovir

Hayashi, K., Hayashi, T., Otsuka, H., & Takeda, Y. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.6.821 · Cited by 60 · see citing works

Investigation of the role of linker moieties in bifunctional tacrine hybrids

Eckroat, T. J., Green, K. D., Reed, R. A., Bornstein, J. J., & Garneau‐Tsodikova, S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.02.047 · Cited by 15 · see citing works

Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases

Gontijo, V. S., Viegas, F. P. D., Ortiz, C. J. C., Silva, M. D. F., Damásio, C. M., Rosa, M. C., Campos, T. G., Couto, D. S., Dias, K. S. T., & Viegas, C. (2019) · Current Neuropharmacology · doi:10.2174/1385272823666191021124443 · Cited by 147 · see citing works

Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018)

Mishra, P., Kumar, A., & Panda, G. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.01.025 · Cited by 128 · see citing works

A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease

Jalili‐Baleh, L., Babaei, E., Abdpour, S., Bukhari, S. N. A., Foroumadi, A., Ramazani, A., Sharifzadeh, M. S., Abdollahi, M. R., & Khoobi, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.05.004 · Cited by 117 · see citing works

Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease

Wu, W., Dai, Y.-C., Li, N., Dong, Z., Gu, T., Shi, Z., Xue, X., Tang, Y., & Duan, J. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1210139 · Cited by 75 · see citing works

Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy

Zagórska, A., & Jaromin, A. (2020) · Molecules · doi:10.3390/molecules25153337 · Cited by 51 · see citing works

Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation

Špilovská, K., Korábečný, J., Šepsová, V., Jun, D., Hrabinová, M., Jošt, P., Múčková, Ľ., Soukup, O., Janočková, J., Kucera, T., et al. (2017) · Molecules · doi:10.3390/molecules22061006 · Cited by 51 · see citing works

Therapeutic Potential of Multifunctional Tacrine Analogues

Przybyłowska, M., Kowalski, S., Dzierzbicka, K., & Inkielewicz‐Stępniak, I. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180412091908 · Cited by 49 · see citing works

Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by β-amyloid1-42 in aged female mice

Giacomeli, R., de Gomes, M. G., Reolon, J. B., Haas, S. E., Colomé, L. M., & Jessé, C. R. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112696 · Cited by 46 · see citing works

Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling

Feng, B., Li, X., Xia, J., & Wu, S. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1347163 · Cited by 42 · see citing works

Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease

Chen, Y., Lin, H., Zhu, J., Gu, K., Li, Q., He, S., Lü, X., Tan, R. X., Pei, Y., Wu, L., et al. (2017) · RSC Advances · doi:10.1039/c7ra04385f · Cited by 39 · see citing works

New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer’s Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase

Basha, S. J., Penumala, M., Yeggoni, D. P., Zinka, R. B., Kumar, P. B., Rao, A. D., Subramanyam, R., & Damu, A. G. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00041 · Cited by 38 · see citing works

Effects of the combination of high-intensity interval training and Ecdysterone on learning and memory abilities, antioxidant enzyme activities, and neuronal population in an Amyloid-beta-induced rat model of Alzheimer’s disease

Gholipour, P., Komaki, A., Ramezani, M., & Parsa, H. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113817 · Cited by 37 · see citing works

Semi-synthesis and biological evaluation of flavone hybrids as multifunctional agents for the potential treatment of Alzheimer's disease

Shi, S.-C., Wang, H., Wang, J., Wang, Y., Xue, X.-B., Hou, Z., Yao, G., Huang, X., Zhao, H., Liu, Q., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103917 · Cited by 35 · see citing works

Advances Toward Multifunctional Cholinesterase and β-Amyloid Aggregation Inhibitors

Panek, D., Wichur, T., Godyń, J., Pasieka, A., & Malawska, B. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0094 · Cited by 32 · see citing works

Development of Activity Rules and Chemical Fragment Design for In Silico Discovery of AChE and BACE1 Dual Inhibitors against Alzheimer’s Disease

Quang-Bao, L., Baecker, D., Dung, D. T. M., Nhung, N. P., Thuần, N. T. D., Nguyen, P. L., Dung, P. T. P., Hương, T. T. L., Rasulev, B., Casañola‐Martín, G. M., et al. (2023) · Molecules · doi:10.3390/molecules28083588 · Cited by 22 · see citing works

Recent advances in the natural product analogues for the treatment of neurodegenerative diseases

Zhang, J., Jiang, P., Wang, S., Li, M., Hao, Z., Guan, W., Pan, J., Wu, J., Zhang, Y., Li, H. L., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107819 · Cited by 13 · see citing works

Flavone Hybrids and Derivatives as Bioactive Agents

Hazai, L., Zsoldos, B., Halmai, M., & Keglevich, P. (2024) · Applied Sciences · doi:10.3390/app14031039 · Cited by 9 · see citing works

Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease

Ortiz, C. J. C., Silva, M. D. F., Gontijo, V. S., Viegas, F. P. D., Dias, K. S. T., & Viegas, C. (2018) · Methods in pharmacology and toxicology · doi:10.1007/7653_2018_2 · Cited by 9 · see citing works

Phyto‐Tacrine Hybrids as Promising Drugs to Treat Alzheimer's Disease

Girek, M. K., & Szymański, P. (2019) · ChemistrySelect · doi:10.1002/slct.201803672 · Cited by 8 · see citing works

Cacao Ameliorates Amyloid Beta-Induced Cognitive and Non-Cognitive Disturbances

Basir, H. S., Mirazi, N., Komaki‬, A., Ramezani, M., & Hosseini, A. (2024) · Neuroscience Insights · doi:10.1177/26331055241280638 · Cited by 7 · see citing works

Psychotomimetic agent BZ (3-quinuclidinyl benzilate)

Fusek, J., Dlabková, A., & Misík, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819090-6.00014-3 · Cited by 6 · see citing works

Hybrid/Chimera Drugs - Part 1 - Drug Hybrids Affecting Diseases of the Central Nervous System

Nudelman, A. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673305662240702071354 · Cited by 5 · see citing works

Flavonoid-Based Derivatives for Modulating Various Targets of Alzheimer’s Disease

Pandey, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_11 · Cited by 3 · see citing works

Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases

Silva, M. D. F., Viegas, F. P. D., Gontijo, V. S., Ortiz, C. J. C., Franco, G. D. R. R., Ernesto, J. T., Damásio, C. M., Fonseca, G. P. D. S., Silva, I. M. F., Massuda, L. E., et al. (2023) · Frontiers in clinical drug research. CNS and neurological disorders · doi:10.2174/9789815123319123110003

BindingDB Entry 50007595: Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).

BindingDB (2021) · UC San Diego · doi:10.7270/q2n87f3n

BindingDB Entry 50018909: A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease.

BindingDB (2024) · UC San Diego · doi:10.7270/q2fx7frv

Multifunctional tacrine–flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease

Li, S., Wang, X., Xie, S., Jiang, N., Wang, K. D. G., Yao, H., Sun, H., & Kong, L. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.09.024 · Cited by 97 · see citing works

Semi-synthesis and biological evaluation of flavone hybrids as multifunctional agents for the potential treatment of Alzheimer's disease

Shi, S.-C., Wang, H., Wang, J., Wang, Y., Xue, X.-B., Hou, Z., Yao, G., Huang, X., Zhao, H., Liu, Q., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103917 · Cited by 35 · see citing works

Design Synthesis and in vitro Evaluation of Tacrine-flavone Hybrids as Multifunctional Cholinesterase Inhibitors for Alzheimer’s Disease

Remya, R. S., Ramalakshmi, N., Nalini, C. N., Niraimathi, V., & Amuthalakshmi, S. (2022) · Current Computer - Aided Drug Design · doi:10.2174/1573409918666220804153754 · Cited by 8 · see citing works

New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer’s Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase

Basha, S. J., Penumala, M., Yeggoni, D. P., Zinka, R. B., Kumar, P. B., Rao, A. D., Subramanyam, R., & Damu, A. G. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00041 · Cited by 38 · see citing works

Design, synthesis and neuroprotective evaluation of novel tacrine–benzothiazole hybrids as multi-targeted compounds against Alzheimer’s disease

Keri, R. S., Quintanova, C., Marques, S. M., Esteves, A. R., Cardoso, S. M., & Santos, M. A. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.028 · Cited by 107 · see citing works